AZ Spin-Out Entasis Appoints Scientific And Clinical Advisory Board
This article was originally published in Scrip
Executive Summary
Entasis Therapeutics, a company focused on bacterial infections, has formed its scientific and clinical advisory board, appointing Paul G. Ambrose, Karen Bush, Stanley A. Nasraway, Mark Noe and Brad Spellberg.